BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 15472333)

  • 1. Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes.
    Tavanti A; Pardini G; Campa D; Davini P; Lupetti A; Senesi S
    J Clin Microbiol; 2004 Oct; 42(10):4726-34. PubMed ID: 15472333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
    Lian CH; Liu WD
    Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
    Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
    J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice.
    Kretschmar M; Felk A; Staib P; Schaller M; Hess D; Callapina M; Morschhäuser J; Schäfer W; Korting HC; Hof H; Hube B; Nichterlein T
    Microb Pathog; 2002 Feb; 32(2):61-70. PubMed ID: 11812212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.
    Naglik JR; Newport G; White TC; Fernandes-Naglik LL; Greenspan JS; Greenspan D; Sweet SP; Challacombe SJ; Agabian N
    Infect Immun; 1999 May; 67(5):2482-90. PubMed ID: 10225911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis.
    Schaller M; Korting HC; Borelli C; Hamm G; Hube B
    Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans secreted aspartyl proteinases.
    Hube B
    Curr Top Med Mycol; 1996 Dec; 7(1):55-69. PubMed ID: 9504059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracellular hydrolytic enzymes and their relevance during Candida albicans infections].
    Stehr F; Felk A; Kretschmar M; Schaller M; Schäfer W; Hube B
    Mycoses; 2000; 43 Suppl 2():17-21. PubMed ID: 11291571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and hydrolytic enzyme characteristics of Candida albicans strains isolated from diabetic patients and their non-diabetic consorts.
    Boriollo MF; Bassi RC; dos Santos Nascimento CM; Feliciano LM; Francisco SB; Barros LM; Spolidório LC; Palomari Spolidório DM
    Oral Microbiol Immunol; 2009 Dec; 24(6):437-50. PubMed ID: 19832795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis.
    De Bernardis F; Arancia S; Morelli L; Hube B; Sanglard D; Schäfer W; Cassone A
    J Infect Dis; 1999 Jan; 179(1):201-8. PubMed ID: 9841840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients.
    Schaller M; Hube B; Ollert MW; Schäfer W; Borg-von Zepelin M; Thoma-Greber E; Korting HC
    J Invest Dermatol; 1999 Mar; 112(3):383-6. PubMed ID: 10084319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis.
    Schaller M; Korting HC; Schäfer W; Bastert J; Chen W; Hube B
    Mol Microbiol; 1999 Oct; 34(1):169-80. PubMed ID: 10540295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.
    Fotedar R; Al-Hedaithy SS
    Mycoses; 2005 Jan; 48(1):62-7. PubMed ID: 15679669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of secreted aspartyl proteinases in Candida albicans keratitis.
    Jackson BE; Wilhelmus KR; Hube B
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3559-65. PubMed ID: 17652724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors.
    White TC; Agabian N
    J Bacteriol; 1995 Sep; 177(18):5215-21. PubMed ID: 7665510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy.
    Malic S; Hill KE; Ralphs JR; Hayes A; Thomas DW; Potts AJ; Williams DW
    Oral Microbiol Immunol; 2007 Jun; 22(3):188-94. PubMed ID: 17488445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections.
    Naglik JR; Rodgers CA; Shirlaw PJ; Dobbie JL; Fernandes-Naglik LL; Greenspan D; Agabian N; Challacombe SJ
    J Infect Dis; 2003 Aug; 188(3):469-79. PubMed ID: 12870130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro study of oral Candida albicans in virulence from HIV-positive individuals].
    Liu XS; Liu HW; Guo ZJ; Luan WM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 May; 40(3):211-4. PubMed ID: 15938881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis.
    Naglik JR; Moyes D; Makwana J; Kanzaria P; Tsichlaki E; Weindl G; Tappuni AR; Rodgers CA; Woodman AJ; Challacombe SJ; Schaller M; Hube B
    Microbiology (Reading); 2008 Nov; 154(Pt 11):3266-3280. PubMed ID: 18957581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility.
    De Bernardis F; Tacconelli E; Mondello F; Cataldo A; Arancia S; Cauda R; Cassone A
    FEMS Immunol Med Microbiol; 2004 May; 41(1):27-34. PubMed ID: 15094164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.